Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Lori S. Hart"'
Autor:
Robyn T. Sussman, Jo Lynne Rokita, Kevin Huang, Pichai Raman, Komal S. Rathi, Daniel Martinez, Kristopher R. Bosse, Maria Lane, Lori S. Hart, Tricia Bhatti, Bruce Pawel, John M. Maris
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
We developed a computational pipeline designed to use RNA sequencing (n = 136) and gene expression profiling (n = 250) data from neuroblastoma tumors to identify cell surface proteins predicted to be highly expressed in MYCN amplified neuroblastomas
Externí odkaz:
https://doaj.org/article/92b8399491b14034a7ca4fb04570dc8f
Autor:
Jo Lynne Rokita, Komal S. Rathi, Maria F. Cardenas, Kristen A. Upton, Joy Jayaseelan, Katherine L. Cross, Jacob Pfeil, Laura E. Egolf, Gregory P. Way, Alvin Farrel, Nathan M. Kendsersky, Khushbu Patel, Krutika S. Gaonkar, Apexa Modi, Esther R. Berko, Gonzalo Lopez, Zalman Vaksman, Chelsea Mayoh, Jonas Nance, Kristyn McCoy, Michelle Haber, Kathryn Evans, Hannah McCalmont, Katerina Bendak, Julia W. Böhm, Glenn M. Marshall, Vanessa Tyrrell, Karthik Kalletla, Frank K. Braun, Lin Qi, Yunchen Du, Huiyuan Zhang, Holly B. Lindsay, Sibo Zhao, Jack Shu, Patricia Baxter, Christopher Morton, Dias Kurmashev, Siyuan Zheng, Yidong Chen, Jay Bowen, Anthony C. Bryan, Kristen M. Leraas, Sara E. Coppens, HarshaVardhan Doddapaneni, Zeineen Momin, Wendong Zhang, Gregory I. Sacks, Lori S. Hart, Kateryna Krytska, Yael P. Mosse, Gregory J. Gatto, Yolanda Sanchez, Casey S. Greene, Sharon J. Diskin, Olena Morozova Vaske, David Haussler, Julie M. Gastier-Foster, E. Anders Kolb, Richard Gorlick, Xiao-Nan Li, C. Patrick Reynolds, Raushan T. Kurmasheva, Peter J. Houghton, Malcolm A. Smith, Richard B. Lock, Pichai Raman, David A. Wheeler, John M. Maris
Publikováno v:
Cell Reports, Vol 29, Iss 6, Pp 1675-1689.e9 (2019)
Summary: Accelerating cures for children with cancer remains an immediate challenge as a result of extensive oncogenic heterogeneity between and within histologies, distinct molecular mechanisms evolving between diagnosis and relapsed disease, and li
Externí odkaz:
https://doaj.org/article/5a7054ef48fe4832b69df7b358c3a0d5
Autor:
John M. Maris, Kristina A. Cole, Bruce Pawel, Andrew C. Wood, Robert W. Schnepp, Giordano Caponigro, Sudha Parasuraman, Sunkyu Kim, Sharon J. Diskin, Edward F. Attiyeh, Erica L. Carpenter, Yimei Li, Daniel Martinez, Lili T. Belcastro, Michael S. Nakazawa, Lori S. Hart, Mike R. Russell, JulieAnn Rader
Supplementary Figure 2 - PDF file 55K, Neuroblastoma tissue microarray. A tissue microarray demonstrates expression of RB in neuroblastoma that is higher in high-risk and MYCN amplified samples compared to low-risk or non-amplified samples (p = 0.03)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1a7b0802e10abd8481e62667a513487
https://doi.org/10.1158/1078-0432.22451172.v1
https://doi.org/10.1158/1078-0432.22451172.v1
Supplementary Table 3 from Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma
Autor:
Yaël P. Mossé, Jennifer L. Harris, Nanxin Li, Shiva Krupa, You Qun He, Giordano Caponigro, Sunkyu Kim, Tove Tuntland, Kathryn B. Grandinetti, Edward Ainscow, Timothy R. Smith, Frederick J. King, Lori S. Hart, Theodore D. Hansel, Renata Sano, Nicole R. Infarinato, Hannah T. Ryles, Kateryna Krytska, Andrew C. Wood
Statistical analysis of in vivo tumor growth delay for dose reduction studies in SH-SY5Y xenografts and Felix-PDX.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::227a0c12d130b485022f0bc562a7c3aa
https://doi.org/10.1158/1078-0432.22463534.v1
https://doi.org/10.1158/1078-0432.22463534.v1
Supplementary Table 1 from Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma
Autor:
Yaël P. Mossé, Jennifer L. Harris, Nanxin Li, Shiva Krupa, You Qun He, Giordano Caponigro, Sunkyu Kim, Tove Tuntland, Kathryn B. Grandinetti, Edward Ainscow, Timothy R. Smith, Frederick J. King, Lori S. Hart, Theodore D. Hansel, Renata Sano, Nicole R. Infarinato, Hannah T. Ryles, Kateryna Krytska, Andrew C. Wood
Neuroblastoma cell line characteristics and Combination Index values in validation panel.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90a396ce515674bcd7428282cfe174af
https://doi.org/10.1158/1078-0432.22463540
https://doi.org/10.1158/1078-0432.22463540
Autor:
John M. Maris, Kristina A. Cole, Bruce Pawel, Andrew C. Wood, Robert W. Schnepp, Giordano Caponigro, Sudha Parasuraman, Sunkyu Kim, Sharon J. Diskin, Edward F. Attiyeh, Erica L. Carpenter, Yimei Li, Daniel Martinez, Lili T. Belcastro, Michael S. Nakazawa, Lori S. Hart, Mike R. Russell, JulieAnn Rader
Supplementary Figure 5 - PDF file 138K, CDK4/6 inhibition does not induce cytotoxicity in neuroblastoma. (A) Caspase 3/7 activation and (B) PARP cleavage were not observed in cell lines with demonstrated sensitivity to LEE011. SN38, a known cytotoxic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::869048f4370f89775cf3649251c7b520
https://doi.org/10.1158/1078-0432.22451163
https://doi.org/10.1158/1078-0432.22451163
Autor:
John M. Maris, Kristina A. Cole, Bruce Pawel, Andrew C. Wood, Robert W. Schnepp, Giordano Caponigro, Sudha Parasuraman, Sunkyu Kim, Sharon J. Diskin, Edward F. Attiyeh, Erica L. Carpenter, Yimei Li, Daniel Martinez, Lili T. Belcastro, Michael S. Nakazawa, Lori S. Hart, Mike R. Russell, JulieAnn Rader
Supplementary Table 1 - PDF file 78K, Genomic aberrations in the Cyclin D/CDK4/CDK6/RB pathway occur frequently in neuroblastoma cell lines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3cffae2b92bf2b443b4e39c6e0a821a
https://doi.org/10.1158/1078-0432.22451157.v1
https://doi.org/10.1158/1078-0432.22451157.v1
Autor:
John M. Maris, Kristina A. Cole, Bruce Pawel, Andrew C. Wood, Robert W. Schnepp, Giordano Caponigro, Sudha Parasuraman, Sunkyu Kim, Sharon J. Diskin, Edward F. Attiyeh, Erica L. Carpenter, Yimei Li, Daniel Martinez, Lili T. Belcastro, Michael S. Nakazawa, Lori S. Hart, Mike R. Russell, JulieAnn Rader
Supplementary Figure 4 - PDF file 88K, Protein level expression of FOXM1 in neuroblastoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::802aa3ec6db98dc111986a7b1f14d7a1
https://doi.org/10.1158/1078-0432.22451166.v1
https://doi.org/10.1158/1078-0432.22451166.v1
Autor:
Yaël P. Mossé, Jennifer L. Harris, Nanxin Li, Shiva Krupa, You Qun He, Giordano Caponigro, Sunkyu Kim, Tove Tuntland, Kathryn B. Grandinetti, Edward Ainscow, Timothy R. Smith, Frederick J. King, Lori S. Hart, Theodore D. Hansel, Renata Sano, Nicole R. Infarinato, Hannah T. Ryles, Kateryna Krytska, Andrew C. Wood
1.Western blot analysis of the cleaved caspase-3 and p53 pathways in Ceritinib and Ribociclib treated cells. 2.Combination ALK and CDK 4/6 inhibition leads to enhanced G0/G1 arrest.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1265c5ddefd7d27de3ad350279dd18db
https://doi.org/10.1158/1078-0432.22463552
https://doi.org/10.1158/1078-0432.22463552
Autor:
John M. Maris, Kristina A. Cole, Bruce Pawel, Andrew C. Wood, Robert W. Schnepp, Giordano Caponigro, Sudha Parasuraman, Sunkyu Kim, Sharon J. Diskin, Edward F. Attiyeh, Erica L. Carpenter, Yimei Li, Daniel Martinez, Lili T. Belcastro, Michael S. Nakazawa, Lori S. Hart, Mike R. Russell, JulieAnn Rader
Supplementary Figure 1 - PDF file 56K, Expression of CDK4, CDK6, CCND1, and RB1 in neuroblastoma patients. Expression analysis of neuroblastoma primary tumors demonstrates that CDK4 expression, and to a lesser extent RB1 expression, is higher in high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acb93c8360adcd5d5854b3a4e47422b7
https://doi.org/10.1158/1078-0432.22451175
https://doi.org/10.1158/1078-0432.22451175